Medicines and pharmaceutical policy featured prominently in the public debate in Iceland in October, with Frumtök contributing to the discussion on access to medicines and the conditions of the Icelandic pharmaceutical market.
Erla Sigríður Skarphéðinsdóttir, pharmacist and Board Member of Frumtök, published an opinion piece in Vísir entitled“Medicines are an investment in people and the future.” The article focused on the value of medicines and innovative treatments as an investment in health, quality of life and society. [https://ww…ramtidinni]
Pétur Magnússon, Managing Director of Frumtök, also discussed access to new medicines and the current situation in Iceland in an interview on Reykjavík síðdegis on Bylgjan. [https://ww…endis-fra-]
Following the interview, Vísir published a news article examining how Iceland’s pharmaceutical pricing policies may affect companies’ willingness to market medicines in Iceland. [https://ww…dendur-fra]